Day: March 27, 2024
Valoe Corporation Financial Statement Release 27 March 2024 at 15.45 Finnish time
THE FOURTH QUARTER IN BRIEF – RESTRUCTURING PROCEEDINGS COMMENCED
During the fourth quarter of 2023, the net sales of Valoe Group, under the IFRS standards, was about EUR 0.01 million (in 2022: EUR 0.4 million). The EBITDA was EUR -0.8 million (EUR -1.2 million) and the EBIT EUR -1.1 million (EUR -1.7 million). The profit for the period was EUR -1.4 million (EUR -2.3 million).
In the fourth quarter, the company’s financial situation remained very tight. The company sought to raise additional financing through the Convertible Bond 1/2023 issued in July 2023. The subscription period of the Convertible Bond continues until 31 July 2024. In addition, the company also entered into financing negotiations with several parties, and the negotiations...
Big Screen Entertainment Group Expands Movie Slate with Acquisition of “Kateland and the Clown”
Written by Customer Service on . Posted in Mergers And Acquisitions.
You Can’t Kill Stephen King
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
Written by Customer Service on . Posted in Dividend Reports And Estimates.
PALO ALTO, Calif., March 27, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the U.S. Bankruptcy Court for the Southern District of Texas (the “Court”) has extended the expiration of the restrictions on transfer of the shares of common stock of Scilex that were previously distributed by Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), Scilex’s former controlling stockholder, to Sorrento’s stockholders as a dividend on January 19, 2023 (the “Dividend Stock”). Such lock-up period was previously set to expire on March 31, 2024. On March 26, 2024, the Court approved a motion to extend the lock-up period of the...
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024
Proof of capability demonstrated with CRISPR-associated transposase (CAST) system being developed to enable >10,000 base pair, targeted genomic integrations
Ultra-small base editing systems (SMART) are the smallest nickase-based systems characterized to-date, designed to enable more efficient delivery via single adeno-associated viruses (AAVs)
Closing of initial public offering provides cash runway to support 2 INDs and 2 additional Development Candidate nominations
EMERYVILLE, Calif., March 27, 2024 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients...
21Shares Launches Revolutionary Toncoin Staking ETP (TONN) for Hassle-Free Staking Rewards
Written by Customer Service on . Posted in Public Companies.
World’s largest issuer of cryptocurrency ETPs releases the 21Shares Toncoin Staking ETP
ZURICH, March 27, 2024 – 21Shares AG (“21Shares”), the world’s largest issuer of cryptocurrency exchange traded products (ETPs) and a subsidiary of 21.co, proudly announces the launch of 21Shares Toncoin Staking ETP. This groundbreaking product provides investors with a seamless way to engage in the staking ecosystem and earn rewards effortlessly.
The Toncoin Staking ETP presents an innovative solution for investors seeking exposure to staking rewards without the complexities of setting up and managing a staking node. With our ETP, investors can now enjoy the benefits of staking Toncoin while leveraging the liquidity and convenience of traditional financial markets.
“Our 21Shares Toncoin Staking ETP opens up a new horizon for...
„Horizonterweiterung für Investoren“: 21Shares bringt Toncoin Staking-ETP auf dem Markt
Written by Customer Service on . Posted in Public Companies.
Unkomplizierter Zugang zu Staking-Erträgen
Zürich/München, 27. März 2024 – 21Shares AG, weltweit größter Anbieter von Krypto-ETPs und Tochtergesellschaft von 21.co, verkündet den Marktstart des 21Shares Toncoin Staking ETP, das mit dem heutigen Tag auf der Schweizer Börse SIX handelbar ist. Das Produkt bietet Anlegern eine Möglichkeit, sich unkompliziert am sogenannten Staking-Ökosystem zu beteiligen und damit auf mühelose Weise Prämien (Staking-Erträge) zu verdienen.
Das Toncoin Staking ETP stellt eine innovative Lösung für Investoren dar, die von den Vorteilen des Staking der Kryptowährung Toncoin profitieren möchten – ohne dass dafür auf eigene sogenannte Staking-Nodes zurückgreifen müssen. Mittels des Toncoin Staking ETPs sind Staking-Erträge bei gleichzeitigem Erhalt von Liquidität und Komfort der traditionellen Finanzmärkte möglich.
“Unser...
21Shares lancia un nuovo ETP su Toncoin, la criptovaluta degli sviluppatori di Telegram
Written by Customer Service on . Posted in Public Companies.
Il più grande emittente di ETP su criptovalute al mondo ha quotato un prodotto sullo staking in ToncoinZurigo, 27 marzo 2024 – 21Shares, società con sede a Zurigo, sussidiaria di 21.co e leader nel segmento degli ETP sulle criptovalute con la più ampia gamma al mondo, annuncia oggi il lancio del nuovo 21Shares Toncoin Staking ETP (ticker: TONN) sulla piattaforma SIX Swiss exchange. Questo prodotto innovativo permetterà agli investitori di percepire un guadagno dallo staking in Toncoin in modo semplice e sicuro.
Lo scopo dell’ETP è quello di offrire la possibilità di ottenere una remunerazione dal processo di staking senza dover essere gestori di un “nodo”, ovvero di quella struttura della blockchain che funge da punto di ingresso o di uscita dal sistema, indispensabile per l’approvazione delle transazioni. In questo modo, chi deciderà...
Eviden opens Security Operations Center in Mexico to enable advanced cybersecurity solutions for local organizations
Written by Customer Service on . Posted in Public Companies.
Eviden LogoEviden LogoEviden’s 17th Security Operations Center located in Mexico to leverage global cybersecurity capabilities for real, local impact
Paris, France – March 27, 2024 – Eviden, the Atos Group business leading in digital, cloud, big data and security, today announces the opening of its new Security Operations Center (SOC) in Monterrey, Mexico, to enable advanced cybersecurity services to organizations across North and South America. The Mexico center is Eviden’s 17th next-generation SOC worldwide, ultimately strengthening the powerful global SOC network.
The increasing number of cyberattacks in today’s business environment are becoming more sophisticated. Eviden’s Security Operations Centers serve as a key differentiator to managing business risk by transforming security environments from highly siloed to holistic,...
Getty Images and United Football League Sign Multi-Year Renewal of Photography Partnership
Written by Customer Service on . Posted in Public Companies.
A Media Snippet accompanying this announcement is available by clicking on this link.
NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, has been named the Official Photographic Agency of the United Football League (UFL). The UFL season kicks off on Saturday, March 30, 2024, when the Birmingham Stallions visit the Arlington Renegades at 1 PM ET.
As part of the multi-year agreement, Getty Images’ award-winning sports photographers and editors will deliver high-quality imagery from every game during the 12-week season. This includes all on and off the field action, such as gameplay, warmups, fan interactions, celebrations and more, all to be distributed exclusively through gettyimages.com.
“We are excited to partner with the United Football League and...
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
Written by Customer Service on . Posted in Public Companies.
TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (CSE: CMND) (FSE: CWY), a biotechnology company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, Clearmind has submitted a patent application under the international Patent Cooperation Treaty.
The patent application refers to the novel proprietary composition of Clearmind’s MEAI compound (5-methoxy-2-aminoindane) with palmitoylethanolamide (“PEA”),...